PIAS1 Antibody - #AF0561
製品説明
*The optimal dilutions should be determined by the end user.
*Tips:
WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.
引用形式: Affinity Biosciences Cat# AF0561, RRID:AB_2834162.
折りたたみ／展開
AR interacting protein; DDXBP1; DEAD/H (Asp-Glu-Ala-Asp/His) box binding protein 1; DEAD/H box binding protein 1; DEAD/H box-binding protein 1; E3 SUMO-protein ligase PIAS1; GBP; Gu binding protein; Gu-binding protein; GU/RH-II; Pias1; PIAS1_HUMAN; Protein inhibitor of activated STAT protein 1; Protein inhibitor of activated STAT, 1; RNA helicase II binding protein; RNA helicase II-binding protein; Zinc finger, MIZ-type containing 3; ZMIZ3;
免疫原
- O75925 PIAS1_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
MADSAELKQMVMSLRVSELQVLLGYAGRNKHGRKHELLTKALHLLKAGCSPAVQMKIKELYRRRFPQKIMTPADLSIPNVHSSPMPATLSPSTIPQLTYDGHPASSPLLPVSLLGPKHELELPHLTSALHPVHPDIKLQKLPFYDLLDELIKPTSLASDNSQRFRETCFAFALTPQQVQQISSSMDISGTKCDFTVQVQLRFCLSETSCPQEDHFPPNLCVKVNTKPCSLPGYLPPTKNGVEPKRPSRPINITSLVRLSTTVPNTIVVSWTAEIGRNYSMAVYLVKQLSSTVLLQRLRAKGIRNPDHSRALIKEKLTADPDSEIATTSLRVSLLCPLGKMRLTIPCRALTCSHLQCFDATLYIQMNEKKPTWVCPVCDKKAPYEHLIIDGLFMEILKYCTDCDEIQFKEDGTWAPMRSKKEVQEVSASYNGVDGCLSSTLEHQVASHHQSSNKNKKVEVIDLTIDSSSDEEEEEPSAKRTCPSLSPTSPLNNKGILSLPHQASPVSRTPSLPAVDTSYINTSLIQDYRHPFHMTPMPYDLQGLDFFPFLSGDNQHYNTSLLAAAAAAVSDDQDLLHSSRFFPYTSSQMFLDQLSAGGSTSLPTTNGSSSGSNSSLVSSNSLRESHSHTVTNRSSTDTASIFGIIPDIISLD
種類予測
Score>80(red) has high confidence and is suggested to be used for WB detection. *The prediction model is mainly based on the alignment of immunogen sequences, the results are for reference only, not as the basis of quality assurance.
High(score>80) Medium(80>score>50) Low(score<50) No confidence
PTMs - O75925 基板として
| Site | PTM Type | Enzyme | Source |
|---|---|---|---|
| A2 | Acetylation | Uniprot | |
| S4 | Phosphorylation | Uniprot | |
| K8 | Sumoylation | Uniprot | |
| K8 | Ubiquitination | Uniprot | |
| S13 | Phosphorylation | Uniprot | |
| S17 | Phosphorylation | P49841 (GSK3B) | Uniprot |
| K30 | Ubiquitination | Uniprot | |
| K34 | Ubiquitination | Uniprot | |
| K40 | Sumoylation | Uniprot | |
| K40 | Ubiquitination | Uniprot | |
| K46 | Sumoylation | Uniprot | |
| K46 | Ubiquitination | Uniprot | |
| S50 | Phosphorylation | Uniprot | |
| K56 | Sumoylation | Uniprot | |
| K56 | Ubiquitination | Uniprot | |
| K58 | Sumoylation | Uniprot | |
| K58 | Ubiquitination | Uniprot | |
| T71 | Phosphorylation | Uniprot | |
| S90 | Phosphorylation | Uniprot | |
| K117 | Sumoylation | Uniprot | |
| K137 | Sumoylation | Uniprot | |
| K137 | Ubiquitination | Uniprot | |
| K140 | Ubiquitination | Uniprot | |
| K152 | Sumoylation | Uniprot | |
| K152 | Ubiquitination | Uniprot | |
| K226 | Ubiquitination | Uniprot | |
| K238 | Sumoylation | Uniprot | |
| K238 | Ubiquitination | Uniprot | |
| S254 | Phosphorylation | Uniprot | |
| S289 | Phosphorylation | Uniprot | |
| S290 | Phosphorylation | Uniprot | |
| T291 | Phosphorylation | Uniprot | |
| R303 | Methylation | Uniprot | |
| S308 | Phosphorylation | Uniprot | |
| K313 | Ubiquitination | Uniprot | |
| K315 | Sumoylation | Uniprot | |
| K315 | Ubiquitination | Uniprot | |
| T327 | Phosphorylation | Uniprot | |
| S328 | Phosphorylation | Uniprot | |
| K339 | Ubiquitination | Uniprot | |
| K369 | Ubiquitination | Uniprot | |
| K408 | Ubiquitination | Uniprot | |
| K419 | Ubiquitination | Uniprot | |
| K420 | Ubiquitination | Uniprot | |
| K453 | Ubiquitination | Uniprot | |
| T463 | Phosphorylation | Uniprot | |
| S466 | Phosphorylation | P68400 (CSNK2A1) | Uniprot |
| S467 | Phosphorylation | P68400 (CSNK2A1) | Uniprot |
| S468 | Phosphorylation | P68400 (CSNK2A1) | Uniprot |
| S476 | Phosphorylation | Uniprot | |
| T480 | Phosphorylation | Uniprot | |
| S483 | Phosphorylation | Uniprot | |
| S485 | Phosphorylation | Uniprot | |
| T487 | Phosphorylation | Uniprot | |
| S488 | Phosphorylation | Uniprot | |
| K493 | Ubiquitination | Uniprot | |
| S497 | Phosphorylation | Uniprot | |
| S503 | Phosphorylation | Uniprot | |
| S506 | Phosphorylation | Uniprot | |
| T508 | Phosphorylation | Uniprot | |
| S510 | Phosphorylation | Uniprot | |
| S522 | Phosphorylation | P49137 (MAPKAPK2) | Uniprot |
研究背景
Functions as an E3-type small ubiquitin-like modifier (SUMO) ligase, stabilizing the interaction between UBE2I and the substrate, and as a SUMO-tethering factor. Plays a crucial role as a transcriptional coregulation in various cellular pathways, including the STAT pathway, the p53 pathway and the steroid hormone signaling pathway. In vitro, binds A/T-rich DNA. The effects of this transcriptional coregulation, transactivation or silencing, may vary depending upon the biological context. Sumoylates PML (at'Lys-65' and 'Lys-160') and PML-RAR and promotes their ubiquitin-mediated degradation. PIAS1-mediated sumoylation of PML promotes its interaction with CSNK2A1/CK2 which in turn promotes PML phosphorylation and degradation (By similarity). Enhances the sumoylation of MTA1 and may participate in its paralog-selective sumoylation. Plays a dynamic role in adipogenesis by promoting the SUMOylation and degradation of CEBPB (By similarity).
Sumoylated.
Nucleus speckle. Nucleus>PML body.
Note: Interaction with CSRP2 may induce a partial redistribution along the cytoskeleton.
Expressed in numerous tissues with highest level in testis.
Interacts with NCOA2 and AR. Interacts with NR2C1; the interaction promotes its sumoylation (By similarity). Interacts with DDX21, CSRP2, AXIN1, JUN, UBE2I, SUMO1, SATB2, PLAG1, TP53 and STAT1 (dimer), following IFNA1-stimulation. Interacts with SP3 (preferentially when SUMO-modified). Interacts with KLF8; the interaction results in SUMO ligation and repression of KLF8 transcriptional activity and of its cell cycle progression into G(1) phase. Interacts with CHUK/IKKA; this interaction induces PIAS1 phosphorylation. Interacts with PTK2/FAK1; the interaction promotes its sumoylation. Interacts with DDX5. Interacts with PML (By similarity). Interacts with MTA1. Interacts with SUMO1P1/SUMO5.
The LXXLL motif is a transcriptional coregulator signature.
The SP-RING-type domain is required for promoting EKLF sumoylation.
Belongs to the PIAS family.
研究領域
· Environmental Information Processing > Signal transduction > Jak-STAT signaling pathway. (View pathway)
· Genetic Information Processing > Folding, sorting and degradation > Ubiquitin mediated proteolysis. (View pathway)
· Human Diseases > Infectious diseases: Viral > Hepatitis C.
Restrictive clause
Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.
For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.